On ECHEMI
Home > Drugs > Yaopharma Co., Ltd.
Yaopharma Co., Ltd.
  • Founded in:

    1997-07-21
  • Country:

    China China
  • Address:

    No. 100, Xingguang Avenue, Renhe Town, Yubei District, Chongqing
  • Tax NO.:

    91500000202851807X
  • Registered Funds:

    196.54 million yuan
  • Website:

  • Email:

Related Drugs
Reboxetine Mesylate
Name Description Content CAS NO. Registered Holders
Reboxetine mesylate

Extract from the above information

More

Extract from the above information

71620-89-8 3
Reboxetine Mesylate
Name Description Content CAS NO. Registered Holders
Reboxetine mesylate

71620-89-8 3
Reboxetine Mesylate Tablets
The main ingredient of this product: Reboxetine mesylate, chemical name: (±)-(2RS)-2-[(RS)-(2-ethoxyphenoxy)benzyl]morpholine mesylate.
Name Description Content CAS NO. Registered Holders
Reboxetine mesylate

Selective norepinephrine (NE) reuptake inhibitors improve patients' mood by selectively blocking NE reuptake and increasing the activity of NE in the central nervous system. They have no affinity for serotonin and dopamine reuptake sites, and almost no affinity for muscarinic, histamine or adrenaline receptors. They are clinically used to treat depression.

More

Selective norepinephrine (NE) reuptake inhibitors improve patients' mood by selectively blocking NE reuptake and increasing the activity of NE in the central nervous system. They have no affinity for serotonin and dopamine reuptake sites, and almost no affinity for muscarinic, histamine or adrenaline receptors. They are clinically used to treat depression.

71620-89-8 3
Reboxetine Mesylate Capsules
The main ingredient of this product: Reboxetine mesylate, chemical name: (±)-(2RS)-2-[(RS)-(2-ethoxyphenoxy)benzyl]morpholine mesylate.
Name Description Content CAS NO. Registered Holders
Reboxetine mesylate

Selective norepinephrine (NE) reuptake inhibitors improve patients' mood by selectively blocking NE reuptake and increasing the activity of NE in the central nervous system. They have no affinity for serotonin and dopamine reuptake sites, and almost no affinity for muscarinic, histamine or adrenaline receptors. They are clinically used to treat depression.

More

Selective norepinephrine (NE) reuptake inhibitors improve patients' mood by selectively blocking NE reuptake and increasing the activity of NE in the central nervous system. They have no affinity for serotonin and dopamine reuptake sites, and almost no affinity for muscarinic, histamine or adrenaline receptors. They are clinically used to treat depression.

71620-89-8 3
Indapamide Tablets
The main ingredient of this product is indapamide, and its chemical name is N-(2-methyl-2,3-dihydro-1H-indolyl)-3-sulfamoyl-4-chloro-benzamide.
Name Description Content CAS NO. Registered Holders
Indapamide

It is a sulfonamide diuretic that works by inhibiting the reabsorption of water and electrolytes in the dilution segment of the distal renal tubular cortex. The antihypertensive mechanism may include regulating calcium influx into vascular smooth muscle cells; stimulating the synthesis of prostaglandins PGE2 and prostaglandins PGI2; reducing the hypersensitivity of blood vessels to vasopressors, thereby inhibiting vasoconstriction. This product has little or no effect on cardiac output, heart rate and rhythm when lowering blood pressure. Long-term use of this product rarely affects glomerular filtration rate or renal blood flow. This drug does not affect the metabolism of blood lipids and carbohydrates.

More

It is a sulfonamide diuretic that works by inhibiting the reabsorption of water and electrolytes in the dilution segment of the distal renal tubular cortex. The antihypertensive mechanism may include regulating calcium influx into vascular smooth muscle cells; stimulating the synthesis of prostaglandins PGE2 and prostaglandins PGI2; reducing the hypersensitivity of blood vessels to vasopressors, thereby inhibiting vasoconstriction. This product has little or no effect on cardiac output, heart rate and rhythm when lowering blood pressure. Long-term use of this product rarely affects glomerular filtration rate or renal blood flow. This drug does not affect the metabolism of blood lipids and carbohydrates.

26807-65-8 28
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.